References
- Isles C. G., Walker L. M., Beevers D. G., et al. Mortality in patients of the Glasgow Blood Pressure Clinic. J. Hypertension 1986; 4: 141–156
- Hole D. J., Hawthorne B. M., Isles CG., et al. Incidence of and mortality from cancer in hypertensive patients. B. M. J. 1993; 306: 609–611
- Lever A. F., Hole D. J., Gillis C. R., et al. Do inhibitors of angiotensin I converting enzyme protect against risk of cancer?. Lancet 1998; 352: 179–184
- Hole D. J., Gillis C. R., McCallum IR., et al. Cancer risk of hypertensive patients taking calcium antagonists. J Hypertension 1998; 16: 119–124
- Hawthorne V. M., Greaves D. A., Beevers D. G. Blood pressure in a Scottish Town. B. M. J. 1974; iii: 600–603
- Registrar General for Scotland Annual Report. A publication of the Government Statistical Service. 1996; 142
- Beevers D. G., Duncan S., Nelson CS., Padfield PL. A blood pressure clinic in a health centre. Postgrad. Med. J. 1976; 52: 683–686
- McInnes G. T., Hole D. J., Meredith P. A., Murray L. S., Reid J. L., Lever AF. Recent decrease of mortality in Glasgow Clinic patients with contribution from ACE inhibitors. In preparation
- Pfeffer M. A., Braunwald E., Moye LA., et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. New Engl. Med. J. 1992; 327: 669–677
- Yusuf S., Pepine C. J., Garces C., et al. Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions. Lancet 1992; 340: 1173–1178
- AIRE Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. Lancet 1993; 342: 821–828
- The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular-ejection fractions and congestive heart failure. New Engl. J. Med. 1991; 325: 293–302